1. Baker, R. W., Chengappa, K. N., Baird, J. W., Steingard, S., Christ, M. A., & Schooler, N. R. (1992). Dec). Emergence of obsessive compulsive symptoms during treatment with clozapine. Journal of Clinical Psychiatry, 53(12), 439–442. https://www.ncbi.nlm.nih.gov/pubmed/1487472.
2. Bareis, N., Olfson, M., Wall, M., & Stroup, T. S. (2021). Sep 30). Variation in psychotropic medication prescription for adults with Schizophrenia in the United States. Psychiatric Services (Washington, D. C.), appips202000932. https://doi.org/10.1176/appi.ps.202000932.
3. Brunette, M. F., Drake, R. E., Xie, H., McHugo, G. J., & Green, A. I. (2006, Oct). Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders. Schizophrenia Bulletin, 32(4), 637–643. https://doi.org/10.1093/schbul/sbl003.
4. Buckman, R. W., & Malan, R. D. (1999). Clozapine for refractory schizophrenia: The Illinois experience. Journal of Clinical Psychiatry, 60(Suppl 1), 18–22. discussion 28–30https://www.ncbi.nlm.nih.gov/pubmed/10037166.
5. Carruthers, J., Radigan, M., Erlich, M. D., Gu, G., Wang, R., Frimpong, E. Y., Essock, S. M., Olfson, M., Castillo, E. G., Miller, G. A., Sederer, L. I., & Stroup, T. S. (2016). Apr 1). An Initiative to improve Clozapine Prescribing in New York State. Psychiatric Services (Washington, D. C.), 67(4), 369–371. https://doi.org/10.1176/appi.ps.201500493.